Home / Lifestyle / Health & Fitness / Article / Blood biomarker may help predict woman's dementia risk 25 years before symptoms: Study

Blood biomarker may help predict woman's dementia risk 25 years before symptoms: Study

A new study found that a blood-based biomarker called phosphorylated tau 217 (p-tau217) can predict a woman's risk of developing dementia up to 25 years before symptoms appear. Higher levels of p-tau217 were strongly associated with future mild cognitive impairment and Alzheimer's disease among cognitively healthy older women

  • WhatsAppBookmarkBookmark
Listen to this article :
Representational image

Representational image

A study has found that a women's risk of developing dementia may be predicted 25 years before symptoms begin through a test of a blood-based biomarker called 'phosphorylated tau 217' -- a protein linked to the brain changes seen in Alzheimer's disease.

Higher levels of phosphorylated tau 217, or p-tau217, were strongly associated with future mild cognitive impairment and dementia -- of which Alzheimer's disease is the most common form -- among older women who were cognitively healthy at the study's start.

Read Next Story
After years of trying, Mumbai couple conceive baby while struggling with sexual health challenges›

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All